5-hydroxydecanoate has been researched along with B16 Melanoma in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakaya, K | 1 |
Mizuno, R | 1 |
Ohhashi, T | 1 |
1 other study available for 5-hydroxydecanoate and B16 Melanoma
Article | Year |
---|---|
B16-BL6 melanoma cells release inhibitory factor(s) of active pump activity in isolated lymph vessels.
Topics: Animals; Anti-Arrhythmia Agents; Arginine; Biological Assay; Culture Media, Conditioned; Cyclooxygen | 2001 |